Xiao Cong Selected Research

Fibrinogen (Factor I)

2/2006

[Hematological changes and related gene mutation of post-severe acute respiratory syndrome patients with osteonecrosis].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiao Cong Research Topics

Disease

2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2017 - 04/2012
1	Pathologic Processes 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Ischemic Stroke 01/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Overweight 02/2020
1	Infections 02/2017
1	Papillomavirus Infections 02/2017
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2016
1	Autistic Disorder (Autism) 02/2016
1	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2016
1	Neuroinflammatory Diseases 01/2014
1	Alzheimer Disease (Alzheimer's Disease) 01/2014
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/2013
1	Cardiotoxicity 01/2013
1	Cardiomyopathies (Cardiomyopathy) 01/2013
1	Sepsis (Septicemia) 01/2013
1	Poisoning 03/2010
1	Osteonecrosis (Kienbock's Disease) 02/2006
1	Activated Protein C Resistance (APC Resistance) 02/2006
1	Inflammation (Inflammations) 05/2002
1	Asthma (Bronchial Asthma) 05/2002

Drug/Important Bio-Agent (IBA)

2	LipidsIBA 01/2022 - 02/2016
2	ApolipoproteinsIBA 01/2021 - 01/2017
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2022
1	Valsartan (Vals)FDA Link 01/2022
1	HDL CholesterolIBA 01/2022
1	Alanine Transaminase (SGPT)IBA 01/2022
1	Apolipoproteins E (ApoE)IBA 01/2021
1	Inosine Diphosphate (IDP)IBA 02/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 02/2017
1	Nucleic AcidsIBA 02/2017
1	Hematoxylin (Haematoxylon)IBA 02/2017
1	Protein Isoforms (Isoforms)IBA 01/2017
1	fms-Like Tyrosine Kinase 3IBA 04/2016
1	Amyloid (Amyloid Fibrils)IBA 01/2014
1	geniposideIBA 01/2014
1	DNA (Deoxyribonucleic Acid)IBA 03/2013
1	ResveratrolIBA 01/2013
1	AntioxidantsIBA 01/2013
1	EndotoxinsIBA 01/2013
1	Advanced Glycation End ProductsIBA 04/2012
1	TeaIBA 04/2012
1	formic acid (formate)IBA 03/2010
1	Protein CIBA 02/2006
1	von Willebrand FactorIBA 02/2006
1	Indicators and Reagents (Reagents)IBA 02/2006
1	Fibrinogen (Factor I)FDA Link 02/2006
1	PlasminogenIBA 02/2006
1	Plasminogen InactivatorsIBA 02/2006
1	Fumigant 93 (D-D)IBA 02/2006
1	Antithrombin IIIIBA 02/2006
1	fibrin fragment D (D-dimer)IBA 02/2006
1	AerosolsIBA 05/2002
1	OvalbuminIBA 05/2002
1	Interleukin-4 (Interleukin 4)IBA 05/2002
1	AntigensIBA 05/2002
1	Messenger RNA (mRNA)IBA 05/2002
1	Interleukin-12 (IL 12)IBA 05/2002

Therapy/Procedure

1	Intraperitoneal Injections 01/2013